UroGen Pharma
URGN
URGN
84 hedge funds and large institutions have $382M invested in UroGen Pharma in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.61% more ownership
Funds ownership: 66.27% → 66.88% (+0.61%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less call options, than puts
Call options by funds: $5.93M | Put options by funds: $7.48M
Holders
84
Holding in Top 10
2
Calls
$5.93M
Puts
$7.48M
Top Buyers
| 1 | +$23.7M | |
| 2 | +$6.38M | |
| 3 | +$3.44M | |
| 4 |
Millennium Management
New York
|
+$2.78M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$2.65M |
Top Sellers
| 1 | -$12M | |
| 2 | -$3.97M | |
| 3 | -$2.68M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$2.61M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.27M |